-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, NM7filUJNPEXV86R3bTdIpxZyIpTRETmp58iL/2//gZWxA+ALnB4+8nym6uiJh5h ajz8hz6IqvXZbmdq6FAlkw== 0000903423-06-000836.txt : 20060706 0000903423-06-000836.hdr.sgml : 20060706 20060706185256 ACCESSION NUMBER: 0000903423-06-000836 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20060703 FILED AS OF DATE: 20060706 DATE AS OF CHANGE: 20060706 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REPLIDYNE INC CENTRAL INDEX KEY: 0001180145 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 BUSINESS ADDRESS: STREET 1: 1450 INFINITE DRIVE CITY: LOUISVILLE STATE: CO ZIP: 80027 BUSINESS PHONE: 303-665-3450 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Tarrant Advisors, Inc CENTRAL INDEX KEY: 0001339181 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-52082 FILM NUMBER: 06949315 BUSINESS ADDRESS: STREET 1: 301 COMMERCE STREET, SUITE 3300 CITY: FORT WORTH STATE: TX ZIP: 76102 BUSINESS PHONE: 817 871 4014 MAIL ADDRESS: STREET 1: 301 COMMERCE STREET, SUITE 3300 CITY: FORT WORTH STATE: TX ZIP: 76102 4 1 tarrant-f4_0706ex.xml X0202 4 2006-07-03 0 0001180145 REPLIDYNE INC RDYN 0001339181 Tarrant Advisors, Inc C/O TEXAS PACIFIC GROUP 301 COMMERCE STREET, SUITE 3300 FORTH WORTH TX 76102 0 0 1 0 Common Stock par value $0.001 2006-07-03 4 J 0 243585 A 243585 I See Footnotes Common Stock par value $0.001 2006-07-03 4 C 0 1957585 A 2201170 I See Footnotes Common Stock par value $0.001 2006-07-03 4 C 0 551744 A 2752914 I See Footnotes Series C Preferred Stock 2006-07-03 4 C 0 9600000 D Common Stock 1957585 0 I See Footnotes Series D Preferred Stock 2006-07-03 4 C 0 2705756 D Common Stock 551744 0 I See Footnotes Represents a dividend by the Issuer to the Reporting Person (as defined below) of shares of the Issuer's common stock (the "Shares") in an aggregate amount of 243,585 Shares, 73,075 of which were issued to TPG Ventures (as defined below) and 170,510 of which were issued to TPG Biotech (as defined below). Upon the consummation of the Issuer's initial public offering of its securities, the Issuer's Series C and Series D Preferred Stock automatically converted to Shares at a conversion ratio of 0.20391517 Shares per 1 share of each such class of Preferred Stock. Prior to such consummation, the Reporting Person (as defined below) held 9,600,000 shares of Series C Preferred Stock and 2,705,756 shares of Series D Preferred Stock of the Issuer. Tarrant Advisors, Inc., a Delaware corporation (the "Reporting Person"), is the general partner of TPG Ventures Professionals, L.P., which is the managing member of TPG Ventures Holdings, L.L.C., which is the sole member of each of TPG Ventures Advisors, L.L.C. and TPG Biotechnology Advisors, L.L.C. TPG Ventures Advisors, L.L.C. is the general partner of TPG Ventures GenPar, L.P., which is the general partner of TPG Ventures, L.P. ("TPG Ventures"). TPG Biotechnology Advisors, L.L.C. is the general partner of TPG Biotechnology GenPar, L.P., which is the general partner of TPG Biotechnology Partners, L.P. ("TPG Biotech," and together with TPG Ventures, the "TPG Funds"). The TPG Funds directly own an aggregate of 2,752,914 Shares of the Issuer. Because of the Reporting Person's relationship to the TPG Funds, the Reporting Person may be deemed to beneficially own the securities directly owned by the TPG Funds. The Reporting Person may also be deemed to beneficially own such securities to the extent of the greater of its direct or indirect pecuniary interest in the profits or capital accounts of the TPG Funds. Pursuant to Rule 16a-1(a)(4) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), this filing shall not be deemed an admission that the Reporting Person is, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owner of any securities beneficially owned in excess of such amount. /s/ David A. Spuria, Vice President 2006-07-06 -----END PRIVACY-ENHANCED MESSAGE-----